Molecular typing is predicated on molecular genetic screening and is not nonetheless routinely readily available. Molecular subtypes and immunohistochemical surrogate markers from the tumors (HR, HER2, triple damaging) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-sixty seven https://katec985vdk2.homewikia.com/user